Study Of Angiomax In Infants Under Six Months With Thrombosis
NCT00043277
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Thrombosis
Interventions
DRUG:
Angiomax (bivalirudin)
Sponsor
The Medicines Company